Trial of SURE vs. Standard Ureteroscopy for Kidney Stones
This study is comparing two ways to treat kidney stones (urolithiasis): Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System, and standard ureteroscopy (URS). SURE uses a steerable catheter with vision, irrigation, and aspiration to remove stones. Standard URS uses a laser to break stones into small pieces, followed by a stent to help them pass. The goal is to see which method leaves less stone material behind (Residual Stone Volume) after 30 days. You may be able to join if you are an adult who needs ureteroscopy with laser lithotripsy and are willing to attend follow-up appointments. You cannot join if you have an untreated urinary tract infection. The study plans to enroll 150 participants, but its current status is unclear.
- Study design
- This is a multi-center study where participants are randomly assigned to one of two treatment groups (SURE or standard URS) with equal chances.
- What's involved
- You would need to be willing and able to return for and respond to all study-related follow-up procedures.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main measurement for success, Residual Stone Volume, is taken 30 days after the procedure.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology
At a glance
Conditions
Where it's being run
5 sites across 5 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Residual Stone Volume (RSV)30-Day